RE:RE:RE:PPI hope you're right! As annoying as they are, some of the company's detractors are not wrong... the stock price will only really appreciate when Else reports at least a couple of sequential quarters of significant revenue growth... or a significant deal (ie Danone). Starting the FDA trial wouldn't hurt either.